{"count": 1, "results": [{"_id": "26856214", "pmid": 26856214, "title": "Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?", "journal": "Am Heart J", "authors": ["Pesaro AE", "Granger CB", "Lopes RD"], "date": "2016-02-01T00:00:00Z", "doi": "10.1016/j.ahj.2015.11.001", "meta_date_publication": "2016 Feb", "meta_volume": "172", "meta_issue": "", "meta_pages": "42-4", "score": 50066.973, "text_hl": "Reduction of @<m>DISEASE_Brain_Ischemia</m> @DISEASE_MESH:D002545 @@@ischemic@@@ events in Improved Reduction of Outcomes: @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Vytorin@@@ Efficacy International Trial: Intensive @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ lowering or @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ antithrombotic effects?", "citations": {"NLM": "Pesaro AE, Granger CB, Lopes RD. Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects? Am Heart J. 2016 Feb;172():42-4. PMID: 26856214", "BibTeX": "@article{26856214, title={Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?}, author={Pesaro AE and Granger CB and Lopes RD}, journal={Am Heart J}, volume={172}, pages={42-4}}"}}]}